ALS Clinical Trials
Find clinical trials for ALS. Search for ALS clinical trials in different cities and states across the United States.
AMX0114 in Adult Participants With Amyotrophic Lateral SclerosisAMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
Sponsor:
Amylyx Pharmaceuticals Inc.
Location:
Code:
NCT06665165
Conditions
ALS
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
AMX0114
Placebo
AMDX-2011P Retinal Tracer in Subjects With Neurodegenerative Diseases Associated With Amyloidogenic ProteinopathyAMDX-2011P Retinal Tracer in Subjects With Neurodegenerative Diseases Associated With Amyloidogenic Proteinopathy
Sponsor:
Amydis Inc.
Location:
Code:
NCT05542576
Conditions
Parkinson Disease
Amyotrophic Lateral Sclerosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
AMDX2011P
Combined Respiratory Training in Persons with ALSCombined Respiratory Training in Persons with ALS
Sponsor:
Nova Southeastern University
Location:
Code:
NCT05913882
Conditions
ALS
Respiratory Insufficiency
Dysphagia
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Respiratory Muscle Strength Training (LVR+EMST)
Feasibility of the BrainGate2 Neural Interface System in Persons With TetraplegiaFeasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
Sponsor:
Leigh R. Hochberg, MD, PhD.
Location:
Code:
NCT05724173
Conditions
Anarthria
Dysarthria
Tetraplegia
Spinal Cord Injuries
Amyotrophic Lateral Sclerosis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
BrainGate Neural Interface System
A Safety and Efficacy Study of ARGX-119 in Adult Patients with Amyotrophic Lateral Sclerosis (ALS)A Safety and Efficacy Study of ARGX-119 in Adult Patients with Amyotrophic Lateral Sclerosis (ALS)
Sponsor:
argenx
Location:
Code:
NCT06441682
Conditions
Amyotrophic Lateral Sclerosis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
ARGX-119
Placebo
First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)
Sponsor:
Regeneron Pharmaceuticals
Location:
Code:
NCT06351592
Conditions
Amyotrophic Lateral Sclerosis (ALS)
Mutation in the Superoxide Dismutase-1 (SOD1) Gene
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ALN-SOD
Diluent
Placebo (PB)
Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)
Sponsor:
UniQure Biopharma B.V.
Location:
Code:
NCT06100276
Conditions
Amyotrophic Lateral Sclerosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
AMT-162
Mitochondrial Capacity Boost in ALS (MICABO-ALS) TrialMitochondrial Capacity Boost in ALS (MICABO-ALS) Trial
Sponsor:
Dallas VA Medical Center
Location:
Code:
NCT04244630
Conditions
Amyotrophic Lateral Sclerosis (ALS)
Eligibility Criteria
Sex: All
Age: 21 - 70+
Healthy Volunteers: Not accepted
Interventions
Antioxidants
Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With EdaravoneBiomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone
Sponsor:
Loma Linda University
Location:
Code:
NCT04097158
Conditions
Amyotrophic Lateral Sclerosis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Sample Collection
What are ALS clinical trials?
Amyotrophic Lateral Sclerosis (ALS) clinical trials are research studies conducted to explore and evaluate new treatments, therapies, and diagnostic tools for ALS, commonly known as Lou Gehrig’s disease. These trials are crucial in the search for effective ways to slow the progression of the disease, manage symptoms, and ultimately find a cure for ALS.
The importance of clinical trials in ALS research
Clinical trials are essential in ALS research as they are the primary method for testing new treatments and interventions. They help in understanding the effectiveness and safety of these treatments in humans. Through these trials, researchers can uncover new insights into the disease, leading to improved care, symptom management, and potentially life-extending therapies for those affected by ALS.
Types of ALS clinical trials
These trials can vary based on the type of intervention being studied, the phase of development, and the specific objectives of the trial. Some common types of ALS clinical trials are:
Treatment trials for ALS symptom management
These trials focus on finding new ways to alleviate the symptoms associated with ALS, such as muscle weakness, difficulty speaking, and respiratory issues. They test new medications, physical therapies, and other interventions aimed at improving the quality of life for individuals living with ALS.
Trials investigating disease-modifying therapies
Disease-modifying trials aim to discover treatments that can alter the course of ALS. These include studies on drugs that could potentially slow down or halt the progression of the disease, providing hope for extending the lives of ALS patients.
Supportive care and rehabilitation trials
Supportive care and rehabilitation trials test interventions designed to support the overall well-being of ALS patients. They include studies on rehabilitation techniques, adaptive equipment, and strategies to assist with daily activities, focusing on maintaining independence and enhancing quality of life.
Trials for emerging therapies in ALS
Emerging therapy trials explore the potential of groundbreaking treatments such as gene therapy, stem cell treatment, and innovative medical devices. These studies represent the cutting-edge of ALS research, seeking novel ways to tackle the disease.
Innovations in ALS treatment through clinical trials
Innovations in ALS treatment through clinical trials are making significant progress in several key areas. One major area is the development of new medications and drug therapies. These trials involve detailed testing of new drugs to see how they affect ALS progression and symptoms.
Another area of research is neuroprotective strategies, which aim to protect nerve cells from damage and slow down the disease's progression, using various medications and supplements.
Additionally, clinical trials are looking into the effects of diet and lifestyle changes on ALS. These studies are testing different dietary supplements and lifestyle adjustments to see if they can help manage ALS and improve patients' quality of life.
Who can participate in ALS clinical trials?
Individuals diagnosed with ALS are typically eligible to participate in clinical trials. Each trial has specific inclusion criteria, which might include the stage of the disease, overall health status, and previous treatment history. Some trials might also be open to individuals without ALS for observational or preventative studies, or to compare health outcomes.
What to expect in an ALS clinical trial
Participating in an ALS clinical trial typically involves a pre-screening process, informed consent, and baseline health assessments. Participants are often randomized into treatment or control groups and undergo the trial's therapy while being closely monitored for effectiveness and side effects. Regular medical check-ups and tests are conducted throughout the trial to track the disease's progression. Participants are required to adhere to specific trial protocols and have the right to withdraw at any time.
Unsure about participating in a clinical trial? Dive into our comprehensive guide to learn about the process, benefits, and potential impact of your involvement. Get the facts you need to make an informed decision today!
How to enroll in an ALS clinical trial
Enrolling in a clinical trial for ALS through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify Your Trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select Your Preferred Location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore Study Details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the Health Profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the Application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.